The 4 analysts offering 12-month price forecasts for Syros Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 19.00 and a low estimate of 3.00. The median estimate represents a +444.07% increase from the last price of 0.92.
The current consensus among 5 polled investment analysts is to Buy stock in Syros Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.45
Reporting Date Nov 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.